Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy
MRM
1 other identifier
interventional
50
1 country
2
Brief Summary
This study was carried out from January 2005 to December 2007 at Mansoura university hospital. Fifty patients who had breast cancer were included in the study, MRM was done for all patients. Patients were randomly divided into two groups. Group І with fibrin glue 4ml of fibrin glue was sprayed on the surgical area with Y canula and group П without fibrin glue. Preoperative, Operative and Postoperative data were collected including postoperative measurement of drainage, date of removal of the drain, state of the wound, incidence of Seroma formation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Jan 2005
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 5, 2008
CompletedFirst Posted
Study publicly available on registry
May 28, 2009
CompletedResults Posted
Study results publicly available
May 28, 2009
CompletedMay 28, 2009
April 1, 2009
2.4 years
December 5, 2008
December 5, 2008
May 27, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Seroma Formation
the mean total drainage volume
within 30 days postoperative
Study Arms (2)
1 fibrin glue
ACTIVE COMPARATOR8 ml of fibrin glue was sprayed on the surgical area with Y canula ( doubleject application system).One milliliter of fibrin glue contains 70-100 mg. fibrinogen, 10-50 u factor 8 aprotinin 3000k iu/ml, 2-9 mg fibronectin,40-120 ug plasminogen ,4 Iu/ml thrombin, 40 mmol cocl2/L (immuno AG/austrial)
2 non fibrin glue
NO INTERVENTIONafter good haemostasis the same sized drain was applied in axillary and breast area and incision was closed. Followed by external compression for 10 minutes in both groups. Drains were left in places until the drainage for the preceding 24 h was less than 20 ml.
Interventions
fibrin glue 8 ml in the bed after modified radical mastectomy in fibrin treated group
Eligibility Criteria
You may qualify if:
- Patients with operable breast cancer
You may not qualify if:
- Patients who received preoperative chemotherapy and radiotherapy were exclude
- Patients with previous axillary surgery
- Patients who underwent simultaneous reconstructive surgery and breast conservative surgery
- Locally advanced breast cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ayman Elnakeeb
Mansoura , Egypt, Mansoura,egypt, 050, Egypt
Ayman Elnakeeb
Al Mansurah, Mansoura, 050, Egypt
Related Publications (2)
Ulusoy AN, Polat C, Alvur M, Kandemir B, Bulut F. Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. Breast J. 2003 Sep-Oct;9(5):393-6. doi: 10.1046/j.1524-4741.2003.09506.x.
PMID: 12968960BACKGROUNDJohnson L, Cusick TE, Helmer SD, Osland JS. Influence of fibrin glue on seroma formation after breast surgery. Am J Surg. 2005 Mar;189(3):319-23. doi: 10.1016/j.amjsurg.2005.01.004.
PMID: 15792759RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Elnakeeb Ayman
- Organization
- Mansoura university hospital
Study Officials
- PRINCIPAL INVESTIGATOR
ayman elnakeeb
Mansoura University Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 5, 2008
First Posted
May 28, 2009
Study Start
January 1, 2005
Primary Completion
June 1, 2007
Study Completion
June 1, 2007
Last Updated
May 28, 2009
Results First Posted
May 28, 2009
Record last verified: 2009-04